Bupropion Hydrochloride Extended-Release Tablets (II)
This product is indicated for the treatment of depressive disorder and seasonal affective disorder and for the cessation of smoking due to nicotine addiction. In clinical practice, it is also used for the treatment of depressive episodes in bipolar affective disorder (used in combination with mood stabilizers) and attention deficit hyperactivity disorder; it has a certain effect on some sexual dysfunctions.
Product Category：
Product Description
[Product Name] Xuanputong®
[Generic Name] Bupropion Hydrochloride Extended-Release Tablets (II)
[Approval No.] 150 mg: GYZZ H20213820; 300 mg: GYZZ H20213821
[Specification] YBH13422021
[Indications] Depressive disorder
[Strength] 150 mg*30 tablets/bottle; 300 mg*30 tablets/bottle
[Storage] Store in airtight containers below 25°C, protected from light.
[Shelf Life] 24 months.
[Medical Insurance] Included in the National Reimbursement Drug List as Category B medicines (on March 01, 2023)
[China General Distributor] Shenzhen Foncoo Pharmaceutical Co., Ltd.
ONLINE MESSAGE
*Note: Please be sure to fill in the information accurately and keep the communication open, we will get in touch with you as soon as possible
Related Products
Contact Us：
Room 1502-1506, Building D2, Nanshan iPark, No. 1001, Xueyuan Avenue, Changyuan Community, Taoyuan Street, Nanshan District, Shenzhen, China.
Follow Us
© COPYRIGHT 2021 Shenzhen Foncoo Pharmaceutical Co., Ltd. ALL RIGHTS RESERVED